APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Healthcare

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

Selected research

Market Analysis & Forecast

Global Equine Healthcare Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchEquine Healthcare Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Healthcare Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Equine Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Healthcare Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Healthcare Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

The top 13 manufacturers held about 75.03% of the market share in 2019.

Report Includes

Read the full market overview

This report presents an overview of global market for Equine Healthcare, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Equine Healthcare, also provides the revenue of main regions and countries. Of the upcoming market potential for Equine Healthcare, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Equine Healthcare revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Equine Healthcare market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Equine Healthcare revenue, projected growth trends, production technology, application and end-user industry.

Equine Healthcare Segment by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Ceva Animal Health

Dechra Veterinary Products

Purina Mills

Norbrook Equine

Virbac

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Equine Healthcare Segment by Type

Equine Diagnostic Products

Equine Therapeutic Products

Equine Supplement Products

Equine Healthcare Segment by Application

Veterinary Hospitals and Clinics

Retail Pharmacies and Drug Stores

Others

Equine Healthcare Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Equine Healthcare in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Equine Healthcare company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Healthcare revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Equine Healthcare Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equine Diagnostic Products Major Player Table 3. Equine Therapeutic Products Major Player Table 4. Equine Supplement Products Major Player Table 5. Global Equine Healthcare Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Veterinary Hospitals and Clinics Major Player Table 7. Retail Pharmacies and Drug Stores Major Player Table 8. Others Major Player Table 9. Equine Healthcare Industry Trends Table 10. Equine Healthcare Industry Drivers Table 11. Equine Healthcare Industry Opportunities and Challenges Table 12. Equine Healthcare Industry Restraints Table 13. Global Equine Healthcare Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Equine Healthcare Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Equine Healthcare Market Share by Region (2021-2026) Table 16. Global Equine Healthcare Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Equine Healthcare Market Share by Region (2027-2032) Table 18. Global Equine Healthcare Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Equine Healthcare Revenue Market Share by Players (2021-2026) Table 20. Global Equine Healthcare Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Equine Healthcare Key Players Headquarters & Area Served Table 22. Global Equine Healthcare Players, Product Type & Application Table 23. Global Equine Healthcare Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Equine Healthcare by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Equine Healthcare Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Equine Healthcare Revenue Market Share by Type (2021-2026) Table 30. Global Equine Healthcare Revenue Market Share by Type (2027-2032) Table 31. Global Equine Healthcare Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Equine Healthcare Revenue Market Share by Application (2021-2026) Table 35. Global Equine Healthcare Revenue Market Share by Application (2027-2032) Table 36. Boehringer Ingelheim Company Information Table 37. Boehringer Ingelheim Business Overview Table 38. Boehringer Ingelheim Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Boehringer Ingelheim Equine Healthcare Product Portfolio Table 40. Boehringer Ingelheim Recent Development Table 41. Merck Animal Health Company Information Table 42. Merck Animal Health Business Overview Table 43. Merck Animal Health Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Merck Animal Health Equine Healthcare Product Portfolio Table 45. Merck Animal Health Recent Development Table 46. Zoetis Company Information Table 47. Zoetis Business Overview Table 48. Zoetis Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Zoetis Equine Healthcare Product Portfolio Table 50. Zoetis Recent Development Table 51. Bayer Animal Health Company Information Table 52. Bayer Animal Health Business Overview Table 53. Bayer Animal Health Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bayer Animal Health Equine Healthcare Product Portfolio Table 55. Bayer Animal Health Recent Development Table 56. Elanco Animal Health Company Information Table 57. Elanco Animal Health Business Overview Table 58. Elanco Animal Health Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Elanco Animal Health Equine Healthcare Product Portfolio Table 60. Elanco Animal Health Recent Development Table 61. Ceva Animal Health Company Information Table 62. Ceva Animal Health Business Overview Table 63. Ceva Animal Health Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Ceva Animal Health Equine Healthcare Product Portfolio Table 65. Ceva Animal Health Recent Development Table 66. Dechra Veterinary Products Company Information Table 67. Dechra Veterinary Products Business Overview Table 68. Dechra Veterinary Products Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Dechra Veterinary Products Equine Healthcare Product Portfolio Table 70. Dechra Veterinary Products Recent Development Table 71. Purina Mills Company Information Table 72. Purina Mills Business Overview Table 73. Purina Mills Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Purina Mills Equine Healthcare Product Portfolio Table 75. Purina Mills Recent Development Table 76. Norbrook Equine Company Information Table 77. Norbrook Equine Business Overview Table 78. Norbrook Equine Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Norbrook Equine Equine Healthcare Product Portfolio Table 80. Norbrook Equine Recent Development Table 81. Virbac Company Information Table 82. Virbac Business Overview Table 83. Virbac Equine Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Virbac Equine Healthcare Product Portfolio Table 85. Virbac Recent Development Table 86. Kyoritsu Seiyaku Company Information Table 87. Kyoritsu Seiyaku Business Overview Table 88. Kyoritsu Seiyaku Equine Healthcare Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 89. Kyoritsu Seiyaku Equine Healthcare Product Portfolio Table 90. Kyoritsu Seiyaku Recent Development Table 91. Vetoquinol Company Information Table 92. Vetoquinol Business Overview Table 93. Vetoquinol Equine Healthcare Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 94. Vetoquinol Equine Healthcare Product Portfolio Table 95. Vetoquinol Recent Development Table 96. Protexin Healthcare Company Information Table 97. Protexin Healthcare Business Overview Table 98. Protexin Healthcare Equine Healthcare Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Protexin Healthcare Equine Healthcare Product Portfolio Table 100. Protexin Healthcare Recent Development Table 101. North America Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Equine Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Equine Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Equine Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Equine Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 115. China Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 116. China Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 117. China Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 118. China Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Equine Healthcare Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Equine Healthcare Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Equine Healthcare Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Equine Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Equine Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Equine Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Equine Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Equine Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Equine Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Equine Healthcare Image Figure 2. Global Equine Healthcare Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Healthcare Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equine Diagnostic Products Image Figure 5. Equine Therapeutic Products Image Figure 6. Equine Supplement Products Image Figure 7. Global Equine Healthcare Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Equine Healthcare Market Size Share 2021 VS 2025 VS 2032 Figure 9. Veterinary Hospitals and Clinics Image Figure 10. Retail Pharmacies and Drug Stores Image Figure 11. Others Image Figure 12. Global Equine Healthcare Market Size (US$ Million) & (2021-2032) Figure 13. Global Equine Healthcare Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Equine Healthcare Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Equine Healthcare Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Equine Healthcare Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Equine Healthcare Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Equine Healthcare Revenue Market Share by Type (2021-2032) Figure 20. Global Equine Healthcare Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Equine Healthcare Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Equine Healthcare Revenue Market Share by Application (2021-2032) Figure 23. North America Equine Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Equine Healthcare Revenue Share by Type (2021-2032) Figure 25. North America Equine Healthcare Revenue Share by Application (2021-2032) Figure 26. North America Equine Healthcare Revenue Share by Country (2021-2032) Figure 27. United States Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Equine Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Equine Healthcare Revenue Share by Type (2021-2032) Figure 32. Europe Equine Healthcare Revenue Share by Application (2021-2032) Figure 33. Europe Equine Healthcare Revenue Share by Country (2021-2032) Figure 34. Germany Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Equine Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Equine Healthcare Revenue Share by Type (2021-2032) Figure 44. China Equine Healthcare Revenue Share by Application (2021-2032) Figure 45. Asia Equine Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Equine Healthcare Revenue Share by Type (2021-2032) Figure 47. Asia Equine Healthcare Revenue Share by Application (2021-2032) Figure 48. Asia Equine Healthcare Revenue Share by Region (2021-2032) Figure 49. Japan Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Equine Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Equine Healthcare Revenue Share by Type (2021-2032) Figure 57. SAMEA Equine Healthcare Revenue Share by Application (2021-2032) Figure 58. SAMEA Equine Healthcare Revenue Share by Country (2021-2032) Figure 59. Brazil Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Equine Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Equine Diagnostic Products
  • Equine Therapeutic Products
  • Equine Supplement Products
Applications
  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores
  • Others
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Ceva Animal Health
  • Dechra Veterinary Products
  • Purina Mills
  • Norbrook Equine
  • Virbac
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Equine Healthcare Market by Type
  3. 1.2.1 Global Equine Healthcare Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equine Diagnostic Products
  5. 1.2.3 Equine Therapeutic Products
  6. 1.2.4 Equine Supplement Products
  7. 1.3 Equine Healthcare Market by Application
  8. 1.3.1 Global Equine Healthcare Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Veterinary Hospitals and Clinics
  10. 1.3.3 Retail Pharmacies and Drug Stores
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Equine Healthcare Market Dynamics
  1. 2.1 Equine Healthcare Industry Trends
  2. 2.2 Equine Healthcare Industry Drivers
  3. 2.3 Equine Healthcare Industry Opportunities and Challenges
  4. 2.4 Equine Healthcare Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Equine Healthcare Market Perspective (2021-2032)
  2. 3.2 Global Equine Healthcare Growth Trends by Region
  3. 3.2.1 Global Equine Healthcare Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Equine Healthcare Market Size by Region (2021-2026)
  5. 3.2.3 Global Equine Healthcare Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Equine Healthcare Revenue by Players
  2. 4.1.1 Global Equine Healthcare Revenue by Players (2021-2026)
  3. 4.1.2 Global Equine Healthcare Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Equine Healthcare Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Equine Healthcare Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Equine Healthcare Key Players Headquarters & Area Served
  7. 4.4 Global Equine Healthcare Players, Product Type & Application
  8. 4.5 Global Equine Healthcare Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Equine Healthcare Market CR5 and HHI
  11. 4.6.3 2025 Equine Healthcare Tier 1, Tier 2, and Tier 3
5 Equine Healthcare Market Size by Type
  1. 5.1 Global Equine Healthcare Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Equine Healthcare Revenue by Type (2021-2032)
  3. 5.3 Global Equine Healthcare Revenue Market Share by Type (2021-2032)
6 Equine Healthcare Market Size by Application
  1. 6.1 Global Equine Healthcare Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Equine Healthcare Revenue by Application (2021-2032)
  3. 6.3 Global Equine Healthcare Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Equine Healthcare Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Equine Healthcare Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Merck Animal Health
  8. 7.2.1 Merck Animal Health Company Information
  9. 7.2.2 Merck Animal Health Business Overview
  10. 7.2.3 Merck Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Animal Health Equine Healthcare Product Portfolio
  12. 7.2.5 Merck Animal Health Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Equine Healthcare Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Equine Healthcare Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 Bayer Animal Health
  20. 7.4.1 Bayer Animal Health Company Information
  21. 7.4.2 Bayer Animal Health Business Overview
  22. 7.4.3 Bayer Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Animal Health Equine Healthcare Product Portfolio
  24. 7.4.5 Bayer Animal Health Recent Developments
  25. 7.5 Elanco Animal Health
  26. 7.5.1 Elanco Animal Health Company Information
  27. 7.5.2 Elanco Animal Health Business Overview
  28. 7.5.3 Elanco Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Elanco Animal Health Equine Healthcare Product Portfolio
  30. 7.5.5 Elanco Animal Health Recent Developments
  31. 7.6 Ceva Animal Health
  32. 7.6.1 Ceva Animal Health Company Information
  33. 7.6.2 Ceva Animal Health Business Overview
  34. 7.6.3 Ceva Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Ceva Animal Health Equine Healthcare Product Portfolio
  36. 7.6.5 Ceva Animal Health Recent Developments
  37. 7.7 Dechra Veterinary Products
  38. 7.7.1 Dechra Veterinary Products Company Information
  39. 7.7.2 Dechra Veterinary Products Business Overview
  40. 7.7.3 Dechra Veterinary Products Equine Healthcare Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Dechra Veterinary Products Equine Healthcare Product Portfolio
  42. 7.7.5 Dechra Veterinary Products Recent Developments
  43. 7.8 Purina Mills
  44. 7.8.1 Purina Mills Company Information
  45. 7.8.2 Purina Mills Business Overview
  46. 7.8.3 Purina Mills Equine Healthcare Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Purina Mills Equine Healthcare Product Portfolio
  48. 7.8.5 Purina Mills Recent Developments
  49. 7.9 Norbrook Equine
  50. 7.9.1 Norbrook Equine Company Information
  51. 7.9.2 Norbrook Equine Business Overview
  52. 7.9.3 Norbrook Equine Equine Healthcare Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Norbrook Equine Equine Healthcare Product Portfolio
  54. 7.9.5 Norbrook Equine Recent Developments
  55. 7.10 Virbac
  56. 7.10.1 Virbac Company Information
  57. 7.10.2 Virbac Business Overview
  58. 7.10.3 Virbac Equine Healthcare Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Virbac Equine Healthcare Product Portfolio
  60. 7.10.5 Virbac Recent Developments
  61. 7.11 Kyoritsu Seiyaku
  62. 7.11.1 Kyoritsu Seiyaku Company Information
  63. 7.11.2 Kyoritsu Seiyaku Business Overview
  64. 7.11.3 Kyoritsu Seiyaku Equine Healthcare Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Kyoritsu Seiyaku Equine Healthcare Product Portfolio
  66. 7.11.5 Kyoritsu Seiyaku Recent Developments
  67. 7.12 Vetoquinol
  68. 7.12.1 Vetoquinol Company Information
  69. 7.12.2 Vetoquinol Business Overview
  70. 7.12.3 Vetoquinol Equine Healthcare Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Vetoquinol Equine Healthcare Product Portfolio
  72. 7.12.5 Vetoquinol Recent Developments
  73. 7.13 Protexin Healthcare
  74. 7.13.1 Protexin Healthcare Company Information
  75. 7.13.2 Protexin Healthcare Business Overview
  76. 7.13.3 Protexin Healthcare Equine Healthcare Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Protexin Healthcare Equine Healthcare Product Portfolio
  78. 7.13.5 Protexin Healthcare Recent Developments
8 North America
  1. 8.1 North America Equine Healthcare Revenue (2021-2032)
  2. 8.2 North America Equine Healthcare Revenue by Type (2021-2032)
  3. 8.2.1 North America Equine Healthcare Revenue by Type (2021-2026)
  4. 8.2.2 North America Equine Healthcare Revenue by Type (2027-2032)
  5. 8.3 North America Equine Healthcare Revenue Share by Type (2021-2032)
  6. 8.4 North America Equine Healthcare Revenue by Application (2021-2032)
  7. 8.4.1 North America Equine Healthcare Revenue by Application (2021-2026)
  8. 8.4.2 North America Equine Healthcare Revenue by Application (2027-2032)
  9. 8.5 North America Equine Healthcare Revenue Share by Application (2021-2032)
  10. 8.6 North America Equine Healthcare Revenue by Country
  11. 8.6.1 North America Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Equine Healthcare Revenue by Country (2021-2026)
  13. 8.6.3 North America Equine Healthcare Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Equine Healthcare Revenue (2021-2032)
  2. 9.2 Europe Equine Healthcare Revenue by Type (2021-2032)
  3. 9.2.1 Europe Equine Healthcare Revenue by Type (2021-2026)
  4. 9.2.2 Europe Equine Healthcare Revenue by Type (2027-2032)
  5. 9.3 Europe Equine Healthcare Revenue Share by Type (2021-2032)
  6. 9.4 Europe Equine Healthcare Revenue by Application (2021-2032)
  7. 9.4.1 Europe Equine Healthcare Revenue by Application (2021-2026)
  8. 9.4.2 Europe Equine Healthcare Revenue by Application (2027-2032)
  9. 9.5 Europe Equine Healthcare Revenue Share by Application (2021-2032)
  10. 9.6 Europe Equine Healthcare Revenue by Country
  11. 9.6.1 Europe Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Equine Healthcare Revenue by Country (2021-2026)
  13. 9.6.3 Europe Equine Healthcare Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Equine Healthcare Revenue (2021-2032)
  2. 10.2 China Equine Healthcare Revenue by Type (2021-2032)
  3. 10.2.1 China Equine Healthcare Revenue by Type (2021-2026)
  4. 10.2.2 China Equine Healthcare Revenue by Type (2027-2032)
  5. 10.3 China Equine Healthcare Revenue Share by Type (2021-2032)
  6. 10.4 China Equine Healthcare Revenue by Application (2021-2032)
  7. 10.4.1 China Equine Healthcare Revenue by Application (2021-2026)
  8. 10.4.2 China Equine Healthcare Revenue by Application (2027-2032)
  9. 10.5 China Equine Healthcare Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Equine Healthcare Revenue (2021-2032)
  2. 11.2 Asia Equine Healthcare Revenue by Type (2021-2032)
  3. 11.2.1 Asia Equine Healthcare Revenue by Type (2021-2026)
  4. 11.2.2 Asia Equine Healthcare Revenue by Type (2027-2032)
  5. 11.3 Asia Equine Healthcare Revenue Share by Type (2021-2032)
  6. 11.4 Asia Equine Healthcare Revenue by Application (2021-2032)
  7. 11.4.1 Asia Equine Healthcare Revenue by Application (2021-2026)
  8. 11.4.2 Asia Equine Healthcare Revenue by Application (2027-2032)
  9. 11.5 Asia Equine Healthcare Revenue Share by Application (2021-2032)
  10. 11.6 Asia Equine Healthcare Revenue by Country
  11. 11.6.1 Asia Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Equine Healthcare Revenue by Country (2021-2026)
  13. 11.6.3 Asia Equine Healthcare Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Equine Healthcare Revenue (2021-2032)
  2. 12.2 SAMEA Equine Healthcare Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Equine Healthcare Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Equine Healthcare Revenue by Type (2027-2032)
  5. 12.3 SAMEA Equine Healthcare Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Equine Healthcare Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Equine Healthcare Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Equine Healthcare Revenue by Application (2027-2032)
  9. 12.5 SAMEA Equine Healthcare Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Equine Healthcare Revenue by Country
  11. 12.6.1 SAMEA Equine Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Equine Healthcare Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Equine Healthcare Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst